Aliskiren (Tekturna) Gets New Warning and Contraindication From FDA – Forbes

The FDA has issued new warnings about antihypertensive drugs containing the direct renin inhibitor aliskiren (including Tekturna, Amturnide, Takamio, and Valturna) when used in combination with ACE inhibitors or angiotensin receptor blockers (ARBs).

Leave a Reply

Your email address will not be published. Required fields are marked *